StockDriftsStockDriftsTop 2 Catalys Pacific, LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 92.81% | 7.90M | $214.1M | +0.00%(+0) | $9.20(+196.36%) | 2026-03-31 | |
| PHAT | Phathom Pharmaceuticals, Inc. | 7.19% | 1.49M | $16.6M | +4.54%(+64.84K) | $12.00(+8.79%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +93.92% | +629.25% |
| Top 20 Holdings Unweighted | +93.92% | +629.27% |
Sign up free to track Catalys Pacific, LLC, compare funds side by side, and get alerts the moment positions change.